PDE4DIP and breast carcinoma: Also, an intronic SNP (rs2863344) in PDE4DIP has been associated with response to capecitabine 50, a common therapy for gastric and breast cancers, which indicates that expression and mutation status of this gene may be relevant to an informed treatment strategy for pancreatic cancer.